EVALUATION OF DNA-POLYMERASE BETA-GENE MUTATION AS A GENETIC-MARKER FOR COLORECTAL-CARCINOMA

Citation
T. Shimoyama et al., EVALUATION OF DNA-POLYMERASE BETA-GENE MUTATION AS A GENETIC-MARKER FOR COLORECTAL-CARCINOMA, Oncology Reports, 4(2), 1997, pp. 391-395
Citations number
23
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
4
Issue
2
Year of publication
1997
Pages
391 - 395
Database
ISI
SICI code
1021-335X(1997)4:2<391:EODBMA>2.0.ZU;2-7
Abstract
DNA polymerase beta is known to be involved in repair of DNA damage. F requent mutation of its gene in the segment encoding amino acids 149-2 97 has been reported in colorectal cancer. To investigate whether muta tion in this region is available as a genetic marker for colorectal ca ncer, 11 primary tumors and 4 liver metastases from 11 patients were e xamined by fragment length analysis and single-strand conformation pol ymorphism (SSCP) analysis of reverse-transcription polymerase chain re action (RT-PCR) products. Although allelic imbalance in the p53 and DC C genes were observed in ten out of eleven primary tumors and all live r metastases using a dinucleotide repeat polymorphism, mutation was no t detected in the DNA polymerase beta mRNA. Neither was it detected in seven colon cancer cell lines. Present results suggest that mutation in this region is uncommon in colorectal cancers and is not a useful g enetic marker for colorectal cancer.